Cargando…
Divergent Gene Activation in Peripheral Blood and Tissues of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis following Infliximab Therapy
OBJECTIVE: The immune inflammatory disorders rheumatoid arthritis (RA), psoriatic arthritis (PsA) and psoriasis (Ps) share common pathologic features and show responsiveness to anti-tumor necrosis factor (TNF) agents yet they are phenotypically distinct. The aim of this study was to examine if anti-...
Autores principales: | Rosenberg, Alexander, Fan, Hongtao, Chiu, Yahui G., Bolce, Rebecca, Tabechian, Darren, Barrett, Rick, Moorehead, Sharon, Baribaud, Frédéric, Liu, Hao, Peffer, Nancy, Shealy, David, Schwarz, Edward M., Ritchlin, Christopher T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204991/ https://www.ncbi.nlm.nih.gov/pubmed/25333715 http://dx.doi.org/10.1371/journal.pone.0110657 |
Ejemplares similares
-
Differences in oxylipin profile in psoriasis versus psoriatic arthritis
por: Coras, Roxana, et al.
Publicado: (2021) -
Infliximab (Remicade) in the treatment of psoriatic arthritis
por: Mease, Philip
Publicado: (2006) -
Effectiveness and safety of infliximab for 11 years in a patient with
erythrodermic psoriasis and psoriatic arthritis
por: Trídico, Lívia Arroyo, et al.
Publicado: (2017) -
Altered Bone Biology in Psoriatic Arthritis
por: Rahimi, Homaira, et al.
Publicado: (2012) -
CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis
por: Chiu, Yahui Grace, et al.
Publicado: (2010)